Changes to its Board of Directors: Oryzon revamps its Board with an expert in Biomedicine and Epigenetics in the US industry [Canadian Business Journal (Canada)]
Synlogic, Inc. (SYBX)
Last synlogic, inc. earnings: 3/12 04:19 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.synlogictx.com/news-and-events/news-releases
Company Research
Source: Canadian Business Journal
Changes to its Board of Directors: Oryzon revamps its Board with an expert in Biomedicine and Epigenetics in the US industry MADRID, SPAIN and CAMBRIDGE, MA –(Marketwired – February 20, 2018) – Oryzon Genomics (ISIN Code: ES0167733015) (MAD: ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today announced by means of a “relevant fact” to the CNMV changes on its corporate governing bodies. The company has incorporated today, February 19 th , to Oryzon Genomics’ Board of Directors Dr. José Carlos Gutiérrez-Ramos, President and CEO of Synlogic, Inc. (NASDAQ: SYBX) as Independent Director. Dr. Gutiérrez-Ramos is a key addition for the company in its expansion plans in the US market. From his extensive experience it is worth noting that, in the period 2009-2015, he was Group Senior Vice-President, WorldWide R&D and Global Head of Biotherapeutics R&D at Pfizer and Head of its Research
Show less
Read more
Impact Snapshot
Event Time:
SYBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SYBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SYBX alerts
High impacting Synlogic, Inc. news events
Weekly update
A roundup of the hottest topics
SYBX
News
- Synlogic, Inc. (NASDAQ: SYBX) was upgraded by analysts at HC Wainwright from a "sell" rating to a "neutral" rating.MarketBeat
- Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Synlogic Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswire
- Synlogic Adopts Limited Duration Stockholders Rights Plan [Yahoo! Finance]Yahoo! Finance
- Synlogic Adopts Limited Duration Stockholders Rights PlanGlobeNewswire
SYBX
Earnings
- 11/9/23 - Miss
SYBX
Sec Filings
- 4/18/24 - Form SC
- 4/4/24 - Form 4
- 4/4/24 - Form 4
- SYBX's page on the SEC website